Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmigo Resources Regulatory News (AMGO)

Share Price Information for Amigo Resources (AMGO)

Share Price is delayed by 15 minutes
Get Live Data
2.375    0.00 (0.00%)
Bid:
2.25
Ask:
2.50
Spread: 0.25 (11.111%)
Market Cap: £28.26m
AMGO Live PriceLast checked at - London Stock Exchange

Intraday Amigo Resources Share Chart

Stabilisation Notice

29 Jun 2018 07:00

RNS Number : 0206T
Amigo Holdings PLC
29 June 2018
 

 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE UNLAWFUL.

 

Amigo Holdings PLC

Stabilisation Notice

 

 

29 June 2018

 

Amigo Holdings PLC hereby gives notice that the entity undertaking stabilisation (the "Stabilising Manager") named below may stabilise the offer of the following securities in accordance with Regulation (EU) No 596/2014 (Market Abuse Regulation) and Commission Delegated Regulation (EU) 2016/1052. Stabilisation transactions aim at supporting the market price of the securities during the stabilisation period. Stabilisation may not necessarily occur and it may cease at any time.

 

The securities:

 

Issuer:

 

Amigo Holdings PLC

Shares:

 

Ordinary Shares of 0.25p each (ISIN: GB00BFFK8T45)

 

Offering size:

 

118,836,758 Shares

Offer price:

 

275 pence per Share

Stabilisation:

 

Stabilising Manager (and central point within the meaning of Commission Delegated Regulation 2016/1052):

 

J.P. Morgan Securities plc, 25 Bank Street, London, E14 5JP, United Kingdom

Contact: Lorenzo Soler

Telephone number: +44 (0) 20 7134 3397

 

Beginning of the stabilisation period:

 

29 June 2018

Stabilisation period to end no later than:

 

28 July 2018

Trading venue where stabilisation may be undertaken:

 

London Stock Exchange

Maximum size of Over-allotment Option:

 

Up to 11,883,675 Shares

Over-allotment Option:

 

Terms:

For the purposes of allowing the Stabilising Manager to cover short positions resulting from any over-allotments and/or from sales of Shares effected by them during the stabilisation period, the Stabilising Manager has been granted an Over-allotment Option, pursuant to which the Stabilising Manager may purchase or procure purchasers for additional Shares at the Offer Price. The Over-allotment Option will be exercisable in whole or in part, upon notice by the Stabilising Manager, at any time on or before the 30th calendar day after the commencement of conditional dealings of the Shares on the London Stock Exchange. Any Over-allotment Shares made available pursuant to the Over-allotment Option will be purchased on the same terms and conditions as the Shares being sold in the Offer.

 

Number of shares covered by Over-allotment Option

 

 

Up to 11,883,675 Shares

Duration:

The Over-allotment Option may be exercised at any time during the stabilisation period.

 

Disclaimer

 

In connection with the offer of the above securities, the Stabilising Manager may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager will take any stabilisation action and any stabilisation action, if begun, may be ended at any time without prior notice. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"), Australia, Canada, Japan or South Africa or any other jurisdiction where such release, publication or distribution would be unlawful. This announcement does not contain or constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or South Africa or any other jurisdiction where such an offer would be unlawful.

The securities of the Issuer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada, Japan or South Africa and, subject to certain exceptions, may not be offered or sold within Australia, Canada, Japan or South Africa or to any national, resident or citizen of Australia, Canada, Japan or South Africa. The release, publication or distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions.

In member states of the European Economic Area (each, a "Relevant Member State"), this announcement and any offer if made subsequently is addressed and directed only at persons who are "qualified investors" within the meaning of the Prospectus Directive ("Qualified Investors"). For these purposes, the expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in a Relevant Member State), and includes any relevant implementing measure in the Relevant Member State and the expression "2010 PD Amending Directive" means Directive 2010/73/EU. In the United Kingdom this announcement is directed exclusively at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), or (ii) who fall within Article 49(2)(A) to (D) of the Order, and (iii) to whom it may otherwise lawfully be communicated, and any investment activity to which it relates will only be engaged in with such persons and it should not be relied on by anyone other than such persons.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAPGUAUQUPRUAB
Date   Source Headline
27th Sep 20233:30 pmRNSResult of AGM
27th Sep 20237:00 amRNSAGM Statement
4th Sep 20233:55 pmRNSNotice of AGM
14th Aug 20235:00 pmRNSAnnual Report and Accounts
27th Jul 20237:00 amRNSFinancial Results for the year ended 31 March 2023
15th Jun 20232:18 pmRNSChange of Registered Office
9th Jun 20237:00 amRNSMarket Update
16th May 20237:00 amRNSBoard change
19th Apr 20237:00 amRNSStatement re. share price movement
3rd Apr 20237:00 amRNSEmployee Share Schemes & Total Voting Rights
3rd Apr 20237:00 amRNSUpdate on Senior Secured Loan Notes
30th Mar 20234:40 pmRNSSecond Price Monitoring Extn
30th Mar 20234:35 pmRNSPrice Monitoring Extension
30th Mar 20233:22 pmRNSUpdate on corporate broker
29th Mar 20234:35 pmRNSPrice Monitoring Extension
29th Mar 20232:05 pmRNSSecond Price Monitoring Extn
29th Mar 20232:00 pmRNSPrice Monitoring Extension
28th Mar 20239:00 amRNSPrice Monitoring Extension
27th Mar 20234:40 pmRNSSecond Price Monitoring Extn
27th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Mar 20231:15 pmRNSBoard changes
23rd Mar 20237:01 amRNSScheme of Arrangement Update
13th Mar 20234:35 pmRNSPrice Monitoring Extension
10th Mar 20237:36 amRNSUpdate on Capital Raise and Scheme of Arrangement
10th Mar 20237:00 amRNSShare Incentive Plan purchase
9th Mar 20234:40 pmRNSSecond Price Monitoring Extn
9th Mar 20234:35 pmRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSGeneral Meeting Statement
7th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20234:35 pmRNSPrice Monitoring Extension
27th Feb 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNS3rd Quarter Results
22nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20234:35 pmRNSPrice Monitoring Extension
16th Feb 20237:00 amRNSNotice of General Meeting
14th Feb 20237:14 amRNSStatement re Conclusion of Enforcement Action
10th Feb 202312:00 pmRNSShare Incentive Plan purchase (“SIP”)
6th Feb 20234:40 pmRNSSecond Price Monitoring Extn
6th Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:40 pmRNSSecond Price Monitoring Extn
31st Jan 20234:35 pmRNSPrice Monitoring Extension
27th Jan 20237:00 amRNSUpdate on Capital Raise and Pilot Lending
18th Jan 202310:02 amRNS(Replacement) Clarification on return to lending
18th Jan 20239:35 amRNSClarification on return to lending
16th Jan 20237:00 amRNSScheme of arrangement update
10th Jan 20234:30 pmRNSShare Incentive Plan purchase
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
6th Dec 20224:40 pmRNSSecond Price Monitoring Extn
6th Dec 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.